Effectiveness and impact of hepatitis B virus vaccination of children with at least one parent born in a hepatitis B virus endemic country: An early assessment

Journal of Epidemiology and Community Health

Volumn 64, Issue 10, 2010, Pages 890-894

  Hontelez, Jan A C ^a   Hahné, Susan ^a   Koedijk, Femke H D ^a   De Melker, Hester E ^a  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; DTP IPV HIB VACCINE; DTP-IPV-HIB VACCINE; HAEMOPHILUS VACCINE; HEPATITIS B VACCINE; POLIOMYELITIS VACCINE; VACCINE;

AGE CLASS; CHILD CARE; CHILD HEALTH; COHORT ANALYSIS; DISEASE INCIDENCE; HEALTH POLICY; HEPATITIS; POLICY MAKING; VACCINATION; VIRAL DISEASE;

ARTICLE; EVALUATION; HEALTH CARE QUALITY; HEPATITIS B; HUMAN; IMMUNIZATION; IMMUNOLOGY; INFANT; INFECTION CONTROL; MIGRATION; NETHERLANDS; NEWBORN; OUTCOME ASSESSMENT; PARENT; PRESCHOOL CHILD; PREVALENCE; PREVENTIVE HEALTH SERVICE; REGISTER; STATISTICS;

CHILD, PRESCHOOL; DIPHTHERIA-TETANUS-PERTUSSIS VACCINE; DISEASE NOTIFICATION; EMIGRATION AND IMMIGRATION; HAEMOPHILUS VACCINES; HEPATITIS B; HEPATITIS B VACCINES; HUMANS; IMMUNIZATION PROGRAMS; IMMUNIZATION SCHEDULE; INFANT; INFANT, NEWBORN; NETHERLANDS; OUTCOME ASSESSMENT (HEALTH CARE); PARENTS; POLIOVIRUS VACCINE, INACTIVATED; PREVALENCE; PROGRAM EVALUATION; REGISTRIES; VACCINES, COMBINED;

NETHERLANDS;

HEPATITIS B VIRUS;

EID: 77957253784     PISSN: 0143005X     EISSN: 14702738     Source Type: Journal    
DOI: 10.1136/jech.2009.092288     Document Type: Article

References (26)

1. Shepard CW, Simard EP, Finelli L, et al. Hepatitis B virus infection: epidemiology and vaccination. Epidemiol Rev 2006;28:112-125
2. Ocama P, Opio CK, Lee WM. Hepatitis B virus infection: current status. Am J Med 2005;118:1413.
3. Liang TJ. Hepatitis B: the virus and disease. Hepatology 2009;49(5 Suppl):S13-21.
4. Edmunds WJ, Medley GF, Nokes DJ, et al. The influence of age on the development of the hepatitis B carrier state. Proc Biol Sci 1993;253:197-201.
5. Fattovich G. Natural history and prognosis of hepatitis B. Semin Liver Dis 2003;23:47-58.
6. Marschall T, Kretzschmar M, Mangen MJ, et al. High impact of migration on the prevalence of chronic hepatitis B in the Netherlands. Eur J Gastroenterol Hepatol 2008;20:1214-1225
7. Hahné S, Ramsay M, Coutinho R. Universal hepatitis B vaccination. Lancet Infect Dis 2008;8:87-8; author reply 90.
8. Health Council of the Netherlands. Universal vaccination against hepatitis B [in Dutch]. The Hague: Health Council of the Netherlands, 2001.
9. EUVAC. EUvac.net: a surveillance community network for vaccine preventable infectious diseases. 2009. http://www.euvac.net (accessed Jan 2009).
10. WHO-CISID. WHO vaccine-preventable diseases: monitoring system 2008 global summary. 2009. http://www.who.int/vaccines/globalsummary/immunization/ scheduleselect.cfm (accessed Jan 2009).
11. Dutch Statistics. http://www.cbs.nl (accessed Jan 2009).
12. Health Council of the Netherlands. The future of the National immunization programme: towards a programme for all ages. The Hague: Health Council Of The Netherlands, 2007.
13. Health Council of the Netherlands. General vaccination against hepatitis B revisited. publication no 2009/03. The Hague: Health Council of the Netherlands, 2009.
14. Lier EA van OPv, Oostenbrug MWM, Zwakhals SLN, et al. [Immunization coverage National Immunization Programme in the Netherlands, year of report 2006-2008]. Bilthoven: RIVM, 2008.
15. Smits LJ, Laar van de M. Hepatitis B and C: compulsory notifications and voluntary notifications in the first half of 1999. [in Dutch]. Infectieziekten bulletin 1999;10:178-182
16. Hahné S, Ramsay M, Balogun K, et al. Incidence and routes of transmission of hepatitis B virus in England and Wales, 1995e2000: implications for immunization policy. J Clin Virol 2004;29:211-220
17. Hahné S, Ramsay M, Soldan K, et al. Hepatitis B incidence among South Asian children in England and Wales: implications for immunisation policy. Arch Dis Child 2003;88:1082-1083
18. Ramsay M, Gay N, Balogun K, et al. Control of hepatitis B in the United Kingdom. Vaccine 1998;(16 Suppl):S52-5.
19. Sonder GJ, Bovee LP, Baayen TD, et al. Effectiveness of a hepatitis A vaccination program for migrant children in Amsterdam, The Netherlands (1992-2004). Vaccine 2006;24:4962-4968
20. Coleman PJ, McQuillan GM, Moyer LA, et al. Incidence of hepatitis B virus infection in the United States, 1976-1994: estimates from the Nationa Health and Nutrition Examination Surveys. J Infect Dis 1998;178: 954-959
21. Shapiro CN, Margolis HS. Impact of hepatitis B virus infection on women and children. Infect Dis Clin North Am 1992;6:75-96.
22. Prislin R, Dyer JA, Blakely CH, et al. Immunization status and sociodemographic characteristics: the mediating role of beliefs, attitudes, and perceived control. Am J Public Health 1998;88:1821-1826
23. Hirasing RA, Verrips GH, Burgmeijer RJ, et al. [Insufficient participation in prevention programs for infants by Turkish, Moroccan, Chinese and Vietnamese parents in large cities]. Ned Tijdschr Geneeskd 1995;139: 2726-2730
24. van der Wal MF, Diepenmaat AC, Pel JM, et al. Vaccination rates in a multicultural population. Arch Dis Child 2005;90:36-40.
25. Hak E, Schonbeck Y, De Melker H, et al. Negative attitude of highly educated parents and health care workers towards future vaccinations in the Dutch childhood vaccination program. Vaccine 2005;23:3103-3107
26. Vermeer K. Second PIENTER-project starts early 2006 [in Dutch]. Inf Bull 2005;16:317.